Blood diagnostics company Seventh Sense Biosystems has raised $16m in a series B round that increased its overall equity funding to $26m.
US-based blood collection and diagnostics company Seventh Sense Biosystems raised $16m in series B funding yesterday in a round that featured pharmaceutical company Novartis and industrial equipment maker Siemens.
Siemens, which invested through its Siemens Financial Services subsidiary, and Novartis were joined in the round by diagnostic technology company Laboratory Corporation of America and venture capital firms Polaris Partners and Flagship Ventures.
Founded in 2008 as part of Flagship incubator Flagship VentureLabs, Seventh Sense aims to simplify blood testing, and…
